Director of Antibody Characterization and Validation Institute for Protein Innovation (IPI)
Recombinant monoclonal antibodies offer advantages over traditional polyclonal reagents, including defined molecular identity, renewable supply, and standardized validation. The Institute for Protein Innovation (IPI) focuses on rigorous characterization and application-aware validation, especially specificity. This presentation highlights validation strategies demonstrating how well-characterized recombinant monoclonals support confident interpretation of cellular staining while improving reliability and reproducibility.
